ARCHIVES

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Contract Awards

November 1, 1996

Benacerraf Named Farber President

February 8, 1980

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.

February 12, 1993

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991